Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CRDL CVE:NOT NASDAQ:PYR NASDAQ:TLRY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCRDLCardiol Therapeutics$1.19-8.8%$1.30$0.77▼$2.63$97.94M1.04308,364 shs532,060 shsNOTNoront ResourcesC$1.10-0.5%C$1.09C$0.23▼C$1.11C$612.18MN/A512,544 shs68,388 shsPYRPyroGenesis Canada$0.38$0.38$0.26▼$1.30$67.96M0.747,701 shs29,889 shsTLRYTilray Brands$0.61+1.9%$0.46$0.35▼$2.15$617.99M1.8231.16 million shs16.24 million shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCRDLCardiol Therapeutics+0.78%-6.47%-9.09%+28.71%-40.91%NOTNoront Resources0.00%0.00%0.00%0.00%0.00%PYRPyroGenesis Canada0.00%0.00%0.00%0.00%0.00%TLRYTilray Brands+1.58%-10.72%+42.65%+33.93%-68.77%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCRDLCardiol Therapeutics2.4457 of 5 stars3.73.00.00.02.70.00.6NOTNoront ResourcesN/AN/AN/AN/AN/AN/AN/AN/APYRPyroGenesis CanadaN/AN/AN/AN/AN/AN/AN/AN/ATLRYTilray Brands1.8449 of 5 stars3.11.00.00.03.20.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCRDLCardiol Therapeutics 3.33Buy$8.00575.11% UpsideNOTNoront Resources 0.00N/AN/AN/APYRPyroGenesis Canada 0.00N/AN/AN/ATLRYTilray Brands 2.25Hold$1.92212.16% UpsideCurrent Analyst Ratings BreakdownLatest CRDL, NOT, PYR, and TLRY Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025CRDLCardiol TherapeuticsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$9.00(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCRDLCardiol TherapeuticsN/AN/AN/AN/A$0.22 per shareN/ANOTNoront ResourcesN/AN/AC$0.01 per share84.23C($0.03) per shareN/APYRPyroGenesis Canada$14.63M4.65N/AN/A$0.07 per share5.43TLRYTilray Brands$788.94M0.78N/AN/A$4.14 per share0.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCRDLCardiol Therapeutics-$26.77M-$0.34N/AN/AN/AN/A-209.63%-141.09%8/11/2025 (Estimated)NOTNoront ResourcesN/A-C$0.15N/A∞N/AN/AN/AN/AN/APYRPyroGenesis Canada-$24.74M-$0.11N/A∞N/A-233.18%-194.66%-68.91%N/ATLRYTilray Brands-$244.98M-$1.05N/AN/AN/A-113.85%-7.40%-6.02%8/4/2025 (Estimated)Latest CRDL, NOT, PYR, and TLRY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025CRDLCardiol Therapeutics-$0.11N/AN/AN/AN/AN/A8/4/2025Q4 2025TLRYTilray Brands-$0.03N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCRDLCardiol TherapeuticsN/AN/AN/AN/AN/ANOTNoront ResourcesN/AN/AN/AN/AN/APYRPyroGenesis CanadaN/AN/AN/AN/AN/ATLRYTilray BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCRDLCardiol Therapeutics0.013.263.26NOTNoront ResourcesN/A0.160.15PYRPyroGenesis Canada0.260.860.78TLRYTilray Brands0.122.621.61Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCRDLCardiol Therapeutics12.49%NOTNoront ResourcesN/APYRPyroGenesis Canada0.41%TLRYTilray Brands9.35%Insider OwnershipCompanyInsider OwnershipCRDLCardiol Therapeutics5.25%NOTNoront ResourcesN/APYRPyroGenesis Canada47.68%TLRYTilray Brands0.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCRDLCardiol Therapeutics2082.65 million78.31 millionNot OptionableNOTNoront Resources101,700559.07 millionN/ANot OptionablePYRPyroGenesis Canada2,020178.88 million93.59 millionNot OptionableTLRYTilray Brands2,6501.01 billion1.00 billionOptionableCRDL, NOT, PYR, and TLRY HeadlinesRecent News About These CompaniesTilray (TLRY) Stock Is Up, What You Need To KnowJuly 16 at 3:15 PM | msn.comTilray Brands (NASDAQ:TLRY) Shares Up 4% - What's Next?July 16 at 1:29 PM | marketbeat.comTilray Brands (NasdaqGS:TLRY) Soars 44% In Last MonthJuly 15 at 9:46 PM | finance.yahoo.comTilray (TLRY) Shares Skyrocket, What You Need To KnowJuly 15 at 9:46 PM | msn.comTilray Brands (NASDAQ:TLRY) Trading Down 6.2% - What's Next?July 15 at 3:20 PM | marketbeat.comTilray Brands stock price is surging: time to buy or sell?July 15 at 11:39 AM | invezz.comITilray Brands stock price is surging: time to buy or sell?July 15 at 11:01 AM | invezz.comIUp Around 40% in Just the Past Month, Could This Red-Hot Growth Stock Rally Even Higher?July 15 at 9:45 AM | fool.comTilray Shares Blazing: What's Behind the 55% Rally This Month?...July 14 at 4:40 PM | marketbeat.comTilray Brands (NASDAQ:TLRY) Stock Price Up 7% - Here's What HappenedJuly 14 at 3:36 PM | marketbeat.comTilray Brands, Inc. (TLRY) Declines More Than Market: Some Information ...July 13, 2025 | finance.yahoo.comCannabis Stocks To Follow Today - July 13thJuly 13, 2025 | marketbeat.comPromising Cannabis Stocks To Follow Now - July 12thJuly 12, 2025 | marketbeat.comTilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for InvestorsJuly 11, 2025 | zacks.comTop Cannabis Stocks To Watch Today - July 11thJuly 11, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Trading Down 5.4% - Should You Sell?July 11, 2025 | marketbeat.com3 Marijuana Stocks To Watch: Key Trends Driving Cannabis Industry GrowthJuly 11, 2025 | marijuanastocks.comMTilray Brands (NASDAQ:TLRY) Trading Down 3.1% - Should You Sell?July 10, 2025 | marketbeat.comPromising Cannabis Stocks To Watch Now - July 10thJuly 10, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Stock Price Up 14.5% - Here's WhyJuly 9, 2025 | marketbeat.comTilray Brands (NASDAQ:TLRY) Sees Large Volume Increase - Should You Buy?July 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 AI Infrastructure Stocks With Strong Growth, Not HypeBy Chris Markoch | June 26, 2025View 3 AI Infrastructure Stocks With Strong Growth, Not HypeTop 5 Stocks for July: Momentum-Driven Picks to Watch NowBy Thomas Hughes | June 30, 2025View Top 5 Stocks for July: Momentum-Driven Picks to Watch Now3 Notable Stocks Just Split: Which One Could Be the Big Winner?By Leo Miller | June 26, 2025View 3 Notable Stocks Just Split: Which One Could Be the Big Winner?Why Centene Stock Dropped 40% — And Whether It's a Buy NowBy Leo Miller | July 8, 2025View Why Centene Stock Dropped 40% — And Whether It's a Buy NowNVDA Greenlight: China H20 Sales Spark 50% Rally PotentialBy Thomas Hughes | July 15, 2025View NVDA Greenlight: China H20 Sales Spark 50% Rally PotentialCRDL, NOT, PYR, and TLRY Company DescriptionsCardiol Therapeutics NASDAQ:CRDL$1.18 -0.12 (-8.85%) As of 02:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.Noront Resources CVE:NOTC$1.10 -0.01 (-0.45%) As of 04/6/2022Noront Resources Ltd., a resource company, engages in the acquisition, development, and exploration of base and precious metals in Canada. It explores for nickel, copper, zinc, platinum group metals, chromite, iron, titanium, vanadium, gold, and silver. The company's flagship property is the Eagle's Nest project located in the James Bay Lowlands, Ontario. The company was formerly known as White Wing Resources Inc. and changed its name to Noront Resources Ltd. in July 1983. Noront Resources Ltd. was incorporated in 1980 and is headquartered in Toronto, Canada.PyroGenesis Canada NASDAQ:PYRPyroGenesis Canada Inc. designs, develops, manufactures, and commercializes plasma processes and solutions worldwide. It offers DROSRITE, a process for enhancing metal recovery from dross without any hazardous by-products; plasma atomization process that allows produce and sell high purity spherical metal powders; PUREVAP, a process to produce high purity metallurgical and solar grade silicon from quartz; and PUREVAP NSiR, which is designed to transform silicon into spherical silicon nano powders and nanowires for use in lithium-ion batteries. The company also provides plasma torches and plasma torch systems used toreplace fossil fuel burners in industrial iron ore pelletization process; plasma arc waste destruction systems for waste destruction onboard ships; steam plasma arc refrigerant cracking systems for the destruction of certain refrigerants, including chlorofluorocarbons, hydrofluorocarbons, and hydrochlorofluorocarbons; plasma arc chemical warfare agent destruction systems, which are mobile platforms for the onsite destruction of chemical warfare agents; plasma resource recovery systems for land-based waste destruction and waste-to-energy applications; plasma torches for waste gasification and combustion; and plasma arc gasification and vitrification. In addition, it offers engineering and manufacturing expertise, and contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, additive manufacturing (including 3D printing), oil and gas, and environmental industries. Further, the company provides installation, commissioning, and start-up services. PyroGenesis Canada Inc. is headquartered in Montréal, Canada.Tilray Brands NASDAQ:TLRY$0.61 +0.01 (+1.87%) As of 02:23 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
